Mannkind Corp financial data

Symbol
MNKD on Nasdaq
Industry
Pharmaceutical Preparations
Location
1 Casper Street, Danbury, CT
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 344 % +15.9%
Quick Ratio 28.1 % -1.68%
Debt-to-equity -280 % -27.7%
Return On Equity -4.92 % -126%
Return On Assets 2.73 %
Operating Margin 18.6 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 275M shares +2.47%
Common Stock, Shares, Outstanding 274M shares +2.32%
Entity Public Float 1.08B USD +19.1%
Common Stock, Value, Issued 2.74M USD +2.16%
Weighted Average Number of Shares Outstanding, Basic 273M shares +2.8%
Weighted Average Number of Shares Outstanding, Diluted 273M shares +2.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 248M USD +57.1%
General and Administrative Expense 43.4M USD +3.16%
Costs and Expenses 202M USD +9.36%
Operating Income (Loss) 46.3M USD +865%
Nonoperating Income (Expense) -32.4M USD -56.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 13.9M USD +67.9%
Income Tax Expense (Benefit) 2.15M USD
Net Income (Loss) Attributable to Parent 11.7M USD +61.7%
Earnings Per Share, Basic 0.05 USD/shares +50%
Earnings Per Share, Diluted 0.05 USD/shares +50%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 96.6M USD +12.1%
Accounts Receivable, after Allowance for Credit Loss, Current 23.3M USD -16%
Inventory, Net 24.8M USD -2.12%
Assets, Current 326M USD +41.6%
Property, Plant and Equipment, Net 85.1M USD +22.5%
Operating Lease, Right-of-Use Asset 4.07M USD -23.6%
Intangible Assets, Net (Excluding Goodwill) 1.03M USD -7.19%
Goodwill 1.93M USD 0%
Other Assets, Noncurrent 15.7M USD +87.5%
Assets 444M USD +41.6%
Accounts Payable, Current 9.56M USD -44.2%
Employee-related Liabilities, Current 12.7M USD +4.25%
Accrued Liabilities, Current 41M USD +11.2%
Contract with Customer, Liability, Current 7.42M USD +113%
Liabilities, Current 80M USD -17.5%
Contract with Customer, Liability, Noncurrent 66.1M USD +9.74%
Operating Lease, Liability, Noncurrent 3.27M USD -29.6%
Other Liabilities, Noncurrent 7.05M USD
Liabilities 670M USD +16.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax 443K USD
Retained Earnings (Accumulated Deficit) -3.22B USD +0.36%
Stockholders' Equity Attributable to Parent -226M USD +13.3%
Liabilities and Equity 444M USD +41.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 6.7M USD +480%
Net Cash Provided by (Used in) Financing Activities -3.47M USD -401%
Net Cash Provided by (Used in) Investing Activities -48.4M USD -451%
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Shares, Issued 274M shares +2.32%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -45.2M USD -381%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 97.4M USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 5.93M USD +60.3%
Deferred Tax Assets, Valuation Allowance 698M USD -0.97%
Deferred Tax Assets, Gross 700M USD -1.05%
Operating Lease, Liability 5.05M USD -9.75%
Depreciation 5.42M USD +31.9%
Payments to Acquire Property, Plant, and Equipment 2.41M USD -71%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -2.01M USD +58.2%
Property, Plant and Equipment, Gross 190M USD +11.8%
Operating Lease, Liability, Current 1.77M USD +87.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Tax Assets, Operating Loss Carryforwards 507M USD -6.62%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 269M USD 0%
Operating Lease, Payments 1.06M USD -29.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.29M USD -31.7%
Share-based Payment Arrangement, Expense 18.7M USD +21.2%
Interest Expense 14.1M USD -9.88%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%